SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-029933
Filing Date
2019-02-07
Accepted
2019-02-06 21:37:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d696437d424b5.htm 424B5 440702
2 GRAPHIC g696437g89r58.jpg GRAPHIC 47764
  Complete submission text file 0001193125-19-029933.txt   507690
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217573 | Film No.: 19573287
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1